Cipherome, Inc. is a unique AI-based pharmacogenomics (PGx) and bioinformatics company focused on accurately predicting adverse drug reactions (ADRs) for personalized care. The unique platform supports the decision in clinical trials at eminent clinical sites in domestic and international partnerships.
Location: United States, California, San Jose
Employees: 11-50
Investors 3
| Date | Name | Website |
| 03.12.2020 | Nautilus V... | nautilusvp... |
| 13.01.2022 | Medivate P... | medivatepa... |
| - | LINEA Inve... | lineainves... |
Mentions in press and media 2
| Date | Title | Description |
| 21.07.2025 | Global Partnership Launches International Health Data Space Initiative to Accelerate AI Driven Precision Medicine | International Health Data Space Initiative Signing Ceremony “We are proud to co-lead this strategic initiative that will fundamentally reshape how health data is accessed and used for research.” — Dr. Ulf NehrbassSAN JOSE, CA, UNITED STATES... |
| - | DHR Health and Cipherome to Pioneer Personalized Medicine Project in Patients Undergoing Percutaneous Coronary Interventions | EDINBURG, Texas--(BUSINESS WIRE)--Feb 28, 2021-- Can a medical tool predict the risk of certain medications based on a patient’s genetics, and, if so, could this information lead to doctors customizing a patient’s drug therapy? The tool bei... |